We recently published 10 Market Stars Behind Millionaire-Making in 2025. Grail Inc. (NASDAQ:GRAL) is one of the top performers. Grail Inc. soared by 379.5 percent in 2025, with the rally primarily ...

By: Gretchen Stipec, M.D., radiologist, Cancer Institute, Long Beach Medical Center Seniors account for nearly 28% of all new ...

Galleri is a blood test that aims to detect over 50 types of cancer early. It analyzes cell-free DNA (cfDNA) and methylation patterns to identify potential cancer signals. The test is intended for ...

GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.) The integration will help streamline the process of ordering the Galleri test ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

MENLO PARK, Calif., May 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new partnership with ...

In January 2022, Anthony Arenz, a 51-year-old living in Mesa, Arizona, breathed a small sigh of relief. The Galleri blood test, which screens for 50 types of cancer, hadn't detected any positive signs ...

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK, Calif. and ...

GRAIL, Inc. is a healthcare company whose mission is to detect cancer early when it can be cured. (PRNewsfoto/GRAIL, Inc.) GRAIL’s Galleri Test Now Directly Available to Physicians in the U.S. Through ...